C07C 62/08
Saturated compounds containing ether groups, [image cpc-sch-c07c-0958.gif] groups,[image cpc-sch-c07c-0959.gif] groups, or[image cpc-sch-c07c-0960.gif]
Official title: Saturated compounds containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups
C07C62/08 (Saturated compounds containing ether groups, [image cpc-sch-c07c-0958.gif] groups,[image cpc-sch-c07c-0959.gif] groups, or[image cpc-sch-c07c-0960.gif]) appears on 37 US grants and 17 published applications in this corpus.
Search patents in C07C- Granted patents
- 37
- Published applications
- 17
- Assignees
- 26
- Inventors
- 106
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor23 Dec 2025US 12,503,422 B2NeuroBo Pharmaceuticals, Inc.
- Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists3 Jan 2023US RE49,352 E1Bristol-Myers Squibb Company
- Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists18 May 2021US 11,007,180 B2Bristol-Myers Squibb Company
- Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists3 Mar 2020US 10,576,062 B2Bristol-Myers Squibb Company
- Anticonvulsant compound28 May 2019US 10,301,263 B2Royal Holloway and Bedford New College
- Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor23 Jul 2026US 2026/0209157 A1MetaVia Inc.
- Process for preparing modulators of eukaryotic initiation factor 2b11 Dec 2025US 2025/0376432 A1Denali Therapeutics Inc.
- Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists20 Feb 2025US 2025/0057815 A1Bristol-Myers Squibb Company
- Radiation-sensitive resin composition, pattern formation method, method for manufacturing substrate, and compound26 Sep 2024US 2024/0319597 A1Jsr Corporation
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications11 Apr 2024US 2024/0116845 A1NucMito Pharmaceuticals Co. Ltd.
Most cited
By later US patents
- Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists21US 10,071,078 B2Bristol-Myers Squibb Company · 2018
- Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists18US 10,576,062 B2Bristol-Myers Squibb Company · 2020
- Perfluorocycloalkane carbonyl fluorides and their derivatives15US 4,739,103 AMinnesota Mining and Manufacturing Company · 1988
- Naphthoquinone derivatives14US 5,053,432 ABurroughs Wellcome Co. · 1991
- Halogen-containing compounds, herbicidal composition containing the same as an active ingredient, and intermediary compounds therefor8US 5,262,385 AMitsubishi Petrochemical Co., Ltd. · 1993